Почетна › Dijabetes tipa 2 › Arizona
Kliničke studije za Dijabetes tipa 2 u državi Arizona
25 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Arizona.
Gradovi u državi Arizona
- Tucson13 студија
- Phoenix8 студија
- Peoria5 студија
- Chandler4 студија
- Gilbert4 студија
- Scottsdale4 студија
- Mesa3 студија
Zvanični tekst studije (na engleskom)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Mission Research Institute - Gilbert, Gilbert
- Helios Clinical Research - Paradise Valley, Paradise Valley
- Arizona Liver Health - Peoria 85381, Peoria
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Arizona Liver Health - Tucson, Tucson
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Arizona Clinical Trials - Chandler, Chandler
- Elite Clinical Studies, Phoenix
- Clinical Research Institute of Arizona, LLC, Sun City West
- и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Arizona Clinical Trials, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Tucson Clinical Research Institute, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
- Noble Clinical Research, LLC, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07915609A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Helios Clinical Research - Phoenix, Phoenix
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Mesa
- Research Site, Phoenix
- Research Site, Tempe
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Desert Clinical Research, Mesa
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 10. 2026. · NCT07527650The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Banner Health, Gilbert
- M3 Wake Research, Tucson
Тражи се учесник
Узраст од 22 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT04101669Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Arizona Clinical Trials - Pecos, Chandler
- Arizona Clinical Trials - Broadway, Tucson
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Gilbert Center for Family Medicine, Gilbert
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Gilbert Center For Family Medicine, Gilbert
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
- Arizona Clinical Trials, Chandler
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 29. 9. 2026. · NCT07223333A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Chandler Clinical Trials, Chandler
- Scottsdale Clinical Trials, Scottsdale
- Sun City Research, Sun City
- и још 1
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Peoria
- AURORA-2 Clinical Site, Phoenix
- AURORA-2 Clinical Site, Tucson
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Sun City
- Research Site, Surprise
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Honor Health, Scottsdale
Тражи се учесникФаза 3
Узраст 45 и старији · Оба пола · Ажурирано 1. 9. 2026. · NCT07797335A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Peoria
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of Arizona, Tucson
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
- Arizona Kidney Disease and Hypertension Center, Phoenix
- Innovative Diabetic Center, Scottsdale
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 4. 8. 2026. · NCT07187479DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Arizona State University, Phoenix
- Phoenix Children's, Phoenix
Тражи се учесникОпсервациона студија
Узраст од 8 до 15 · Оба пола · Ажурирано 7. 5. 2026. · NCT06525259Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.